Fibromyalgia in Patient With Impaired Fasting Glucose

NCT03871946 | Completed

• 1 other identifier: Hitit University
• Study Type: observational
• Target: 146
• Locations: 0 countries
• Sites: N/A

Brief Summary

To assess the frequency of fibromyalgia among women with impaired fasting glucose.

Conditions

Fibromyalgia

Outcome Measures

Primary Outcomes (1)

• the frequency of fibromyalgia among women with impaired fasting glucose.

  Moreover, a significantly higher proportion of Group 1 patients (26%, n = 19) than Group 2 patients (11%, n = 8) were diagnosed with FM

  16 month

Study Arms (2)

Experimental group

Experimental group subjects with impaired fasting glucose (IFG) (Group 1) underwent an oral glucose tolerance test (OGTT), and patients with levels \> 140 mg/dL at the 2nd hour were excluded because they were diagnosed with "impaired glucose tolerance"

Diagnostic Test: oral glucose tolerance test (OGTT)

control group

The control group (Group 2) comprised 73 patients whose fasting blood glucose level was \<100 mg/dL and who agreed to participate in the study.

Diagnostic Test: oral glucose tolerance test (OGTT)

Interventions

oral glucose tolerance test (OGTT) DIAGNOSTIC_TEST

Implementation of OGTT: The patient was seated in a quiet room after 10-12 h of overnight fasting, and blood samples were drawn. Thereafter, 75 g glucose solution dissolved in 300 mL of water was administeredwithin 5 min. Two hours after this,another blood sample was drawn. During the test, the patient wasn't allowed to rest and eat, but not smoke.

Experimental group; control group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

18-65 years female patients

You may qualify if:

• the study group subjects: fasting blood glucose level was between 100 and 126 mg/dL;
• the control group subjects: fasting blood glucose level was \< 100 mg/dL.

You may not qualify if:

• Patients with a severe systemic disease (chronic kidney disease, liver disease etc. ),
• psychiatric disease,
• hypothyroidism or hyperthyroidism,
• any connective tissue disease
• patients who used medications that influenced the fibromyalgia symptoms, such as analgesics, antidepressants, and anticonvulsive medications

Sponsors & Collaborators

• Hitit University: lead
• Eskisehir Osmangazi University: collaborator

MeSH Terms

Conditions

Fibromyalgia

Interventions

Glucose Tolerance Test

Condition Hierarchy (Ancestors)

Muscular Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Neuromuscular Diseases; Nervous System Diseases

Intervention Hierarchy (Ancestors)

Blood Chemical Analysis; Clinical Chemistry Tests; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Diagnostic Techniques, Endocrine; Investigative Techniques

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: March 1, 2019
• First Posted: March 12, 2019
• Study Start: August 15, 2015
• Primary Completion: December 31, 2016
• Study Completion: December 31, 2016
• Last Updated: March 12, 2019

Record last verified: 2019-03

Data Sharing

• IPD Sharing: Will not share